Delivery Order SPE2DB20D3103-SPE2DB21FN9S3

Award Date 5/27/21
Potential Completion Date 5/28/21
Potential Value $11K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,082.04 delivery order was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, for the Prime Vendor Pharmacy Branch in Philadelphia. The award is a firm fixed price contract with an ultimate completion date of April 29, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,714.22 for pharmaceutical and medical supply distribution. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 3, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Prime Vendor Pharmaceutical Branch-Philadelphia valued at $1,200.50. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of November 30, 2020. It is a firm fixed-price delivery order contract type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $50,327.73 for pharmaceutical and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) for the Prime Vendor Pharmaceutical Branch in Philadelphia. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,754.77 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" from the Defense Logistics Agency (DLA). The contract has an ultimate completion date of September 2, 2020 and was awarded on September 1, 2020. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,759.20 for a "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The award has an ultimate completion date of March 15, 2021 and is a Firm Fixed Price contract. This order is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for a Prime Vendor Pharmaceutical Branch-Philadelphia contract with the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $3,934.14, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 16, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Delivery Order valued at $10,391.74 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,374.53, is a delivery order for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has a completion date of February 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,916.35 for "Prime Vendor Pharm Branch-Philadelphia" under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FN9S3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $10,763.22 for pharmaceutical and medical supply services. The award was made by the Defense Logistics Agency (DLA) and supports the Prime Vendor Pharmaceutical Branch-Philadelphia program. The contract has a firm fixed-price pricing type and an ultimate completion date of May 28, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items, to support military healthcare programs globally. The contract award reviewed did not have a set-aside designation, indicating full and open competition.

Generated 2/27/25, 1:35 PM